Jagjit S. Gill

464 citations
19 papers · 407 indexed · h-index 13
Topics
Nerve injury and regeneration (5 papers)Cancer Treatment and Pharmacology (4 papers)Sphingolipid Metabolism and Signaling (3 papers)

In The Last Decade

Jagjit S. Gill

19 papers receiving 397 citations

Peers

Jagjit S. Gill
Comparison fields: 5 of 76
  • Molecular Biology 163
  • Cellular and Molecular Neuroscience 129
  • Oncology 73
  • Surgery 56
  • Physiology 51
Replace Yohann Demont with:
Yohann Demont France
Hea Nam Hong South Korea
Amanda M. Smith United States
Kristy Boyle Australia
Brunella Cristofaro United Kingdom
Yujun Pan China
Mario Mauri Italy
S. Hattori Japan
Jenny Marzahn Germany
Zhenjie Zhu China
Jagjit S. Gill relative to Yohann Demont France Yohann Demont's profile →
Citations per field
00.5×1.5×2.3×
Yohann Demont · 1×
Citations per year

Countries citing papers authored by Jagjit S. Gill

Since Specialization
Citations

This map shows the geographic impact of Jagjit S. Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jagjit S. Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jagjit S. Gill more than expected).

Fields of papers citing papers by Jagjit S. Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jagjit S. Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jagjit S. Gill. The network helps show where Jagjit S. Gill may publish in the future.

Co-authorship network of co-authors of Jagjit S. Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Jagjit S. Gill. A scholar is included among the top collaborators of Jagjit S. Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jagjit S. Gill. Jagjit S. Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 8
2 5
3 2
4 35
5 22
6 53
7 17
8 18
9 37
10 4
11 6
12 29
13 32
14 44
15 2
16 16
17 24
18 32
19 21

About Jagjit S. Gill

Jagjit S. Gill is a scholar working on Cellular and Molecular Neuroscience, Oncology and Cell Biology, having authored 19 papers that have together received 407 indexed citations. Recurring topics across this work include Nerve injury and regeneration (5 papers), Cancer Treatment and Pharmacology (4 papers) and Sphingolipid Metabolism and Signaling (3 papers). The work is most often cited by research in Developmental Neuroscience (42 citations), Cellular and Molecular Neuroscience (129 citations) and Hematology (42 citations). Jagjit S. Gill has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Anthony J. Windebank, Joseph F. Poduslo, Angelo Schenone, David A. Zacharias, Jewel L. Podratz, B.T. Evans, Stephen Honeybul, Whyte G. Owen, Roy O. Weller and Xun Zhu. Their work appears in journals such as Biomaterials, Brain Research and Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026